Correlation Between Monte Rosa and Pardes Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Pardes Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Pardes Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Pardes Biosciences, you can compare the effects of market volatilities on Monte Rosa and Pardes Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Pardes Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Pardes Biosciences.

Diversification Opportunities for Monte Rosa and Pardes Biosciences

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Monte and Pardes is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Pardes Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pardes Biosciences and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Pardes Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pardes Biosciences has no effect on the direction of Monte Rosa i.e., Monte Rosa and Pardes Biosciences go up and down completely randomly.

Pair Corralation between Monte Rosa and Pardes Biosciences

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.55 times more return on investment than Pardes Biosciences. However, Monte Rosa is 1.55 times more volatile than Pardes Biosciences. It trades about 0.03 of its potential returns per unit of risk. Pardes Biosciences is currently generating about 0.02 per unit of risk. If you would invest  796.00  in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would earn a total of  64.00  from holding Monte Rosa Therapeutics or generate 8.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy28.78%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Pardes Biosciences

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Pardes Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Monte Rosa and Pardes Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Pardes Biosciences

The main advantage of trading using opposite Monte Rosa and Pardes Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Pardes Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will offset losses from the drop in Pardes Biosciences' long position.
The idea behind Monte Rosa Therapeutics and Pardes Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital